DBDavid Andrew Broadbent

David Andrew Broadbent

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


David Andrew Broadbent has a total of 160 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Normal values of high-resolution transmural perfusion distribution metrics for automated quantitative pixel-wise myocardial perfusion cardiovascular magnetic resonance

    by Christel H. Kamani, Louise Brown, Thomas Anderton, Raluca Tomoaia, Chin Soo, Gaurav S. Gulsin, David A. Broadbent, Jian L. Yeo, Alice L. Wood, Christopher E.D. Saunderson, et al.

  • Open Access

    Optimisation of cone beam CT radiotherapy imaging protocols using a novel 3D printed head and neck anthropomorphic phantom

    by Meshal Alzahrani, Christopher O’hAra, David Bird, Jack P C Baldwin, Mitchell Naisbit, Irvin Teh, David A Broadbent, Bashar Al-Qaisieh, Emily Johnstone, Richard Speight

    Objective. This study aimed to optimise Cone Beam Computed Tomography (CBCT) protocols for head and neck (H&N) radiotherapy treatments using a 3D printed anthropomorphic phantom. It focused on precise patient positioning in conventional treatment and adaptive radiotherapy (ART). Approach. Ten CBCT protocols were evaluated with the 3D-printed H&N anthropomorphic phantom, including one baseline protocol currently used at our centre and nine new protocols. Adjustments were made to milliamperage and exposure time to explore their impact on radiation dose and image quality. Additionally, the effect on image quality of varying the scatter correction parameter for each of the protocols was assessed. Each protocol was compared against a reference CT scan. Usability was assessed by three Clinical Scientists using a Likert scale, and statistical validation was performed on the findings. Main results. The work revealed variability in the effectiveness of protocols. Protocols optimised for lower radiation exposure maintained sufficient image quality for patient setup in a conventional radiotherapy pathway, suggesting the potential for reducing patient radiation dose by over 50% without compromising efficacy. Optimising ART protocols involves balancing accuracy across brain, bone, and soft tissue, as no single protocol or scatter correction parameter achieves optimal results for all simultaneously. Significance. This study underscores the importance of optimising CBCT protocols in H&N radiotherapy. Our findings highlight the potential to maintain the usability of CBCT for bony registration in patient setup while significantly reducing the radiation dose, emphasizing the significance of optimising imaging protocols for the task in hand (registering to soft tissue or bone) and aligning with the as low as reasonably achievable principle. More studies are needed to assess these protocols for ART, including CBCT dose measurements and CT comparisons. Furthermore, the novel 3D printed anthropomorphic phantom demonstrated to be a useful tool when optimising CBCT protocols.


  • Open Access

    Assessing suitability and stability of materials for a head and neck anthropomorphic multimodality (MRI/CT) phantoms for radiotherapy

    by Meshal Alzahrani, David A Broadbent, Irvin Teh, Bashar Al-Qaisieh, Richard Speight

    Objective: This study aims to identify and evaluate suitable and stable materials for developing a head and neck anthropomorphic multimodality phantom for radiotherapy purposes. These materials must mimic human head and neck tissues in both computed tomography (CT) and magnetic resonance imaging (MRI) and maintain stable imaging properties over time and after radiation exposure, including the high levels associated with linear accelerator (linac) use. Approach: Various materials were assessed by measuring their CT numbers and T1 and T2 relaxation times. These measurements were compared to literature values to determine how closely the properties of the candidate materials resemble those of human tissues in the head and neck region. The stability of these properties was evaluated monthly over a year and after radiation exposure to doses up to 1000 Gy. Statistical analyzes were conducted to identify any significant changes over time and after radiation exposure. Main results: 10% and 12.6% Polyvinyl alcohol cryogel (PVA-c) both exhibited T1 and T2 relaxation times and CT numbers within the range appropriate for brain grey matter. 14.3% PVA-c and some plastic-based materials matched the MRI properties of brain white matter, with CT numbers close to the clinical range. Additionally, some plastic-based materials showed T1 and T2 relaxation times consistent with MRI properties of fat, although their CT numbers were not suitable. Over time and after irradiation, 10% PVA-c maintained consistent properties for brain grey matter. 12.6% PVA-c’s T1 relaxation time decreased beyond the range after the first month. Significance: This study identified 10% PVA-c as a substitute for brain grey matter, demonstrating stable imaging properties over a year and after radiation exposure up to 1000 Gy. However, the results highlight a need for further research to find additional materials to accurately simulate a wider range of human tissues.


  • Open Access

    Relationship between myocardial strain, coronary microvascular dysfunction, and myocardial extracellular volume in patients with type 2 diabetes: a cross-sectional CMR study

    by A Bojer, M H Soerensen, S H Madsen, D A Broadbent, S Plein, P Gaede, P L Madsen

    Background: Patients with diabetes often develop heart failure with preserved ejection and often demonstrate early indications of myocardial dysfunction by decreased strain, notably the global longitudinal (GLS). The underlying myocardial phenotypical changes in patients with diabetes are coronary microvascular dysfunction and myocardial interstitial fibrosis. The relation of these to strain-indicators of early systolic dysfunction is not established. Purpose: We hypothesized that coronary microvascular function and interstitial fibrosis contribute to the subclinical myocardial dysfunction seen in patients with diabetes. Method: With gadolinium contrast and adenosine-stress magnetic resonance imaging, we determined myocardial blood flow (MBF) and perfusion ratio (MPR) and extracellular volume (ECV; an imaging biomarker of diffuse fibrosis) in 211 patients with type 2 diabetes without macrovascular coronary artery disease and 25 control subjects. Left ventricular (LV) function was determined from its ejection fraction and 3D feature tracking of GLS, circumferential (GCS), and radial strains (GRS). Results: Without a significant age- or sex-differences to control subjects, patients (median age 57 years [IQR 50, 67], 70% males) had a median diabetes duration of 12 [IQR 6, 18] years. LV ejection fraction was normal and similar to controls. Compared to control subjects (GLS -13.9±2.0%), GLS, GCS and GRS were reduced in the total diabetes cohort, and GLS was reduced also in the subgroup of patients without any diabetes complications (total -11.6±3.0%; without-complications -12.3±2.6%). GLS, but not GCS or GRS or LVEF, was associated with albuminuria (b (95%CI) 1.09 (0.22-1.96)) and autonomic neuropathy (b (95%CI) 1.43 (0.54-2.31)). Independently of ECV, a 10% increase in MBF at adenosine-stress and MPR was associated with improved GLS in uni- and multivariable regression analyses. A 10% increase in ECV was associated with a decrease in GLS in univariable and multivariable regression analysis, but this was abolished when adjusted for MPR. GLS showed a moderate ability to discriminate a significantly lowered myocardial blood flow at stress defined as <1.49 mL/min/g (AUC 0.72, GLS threshold -11.5%; sensitivity 75% and specificity 53%) and myocardial perfusion ratio defined as as 31% (AUC 0.60, GLS threshold -13.5 resulted in a sensitivity of 72% and a specificity of 34%). Conclusion: Of the two important phenotypical changes seen with type 2 diabetes, microvascular dysfunction and fibrosis, coronary microvacular dysfunction demonstrates the more important relation to early systolic compromise as determined from the left ventricle global longitudinal strain.Associations of Systolic parametersROC curve

  • Perfusion MRI in the heart: First-pass perfusion

    by N. Sharrack, J.D. Biglands, S. Plein, D.A. Broadbent

  • Myocardial Blood Flow Determination From Contrast‐Free Magnetic Resonance Imaging Quantification of Coronary Sinus Flow

    by Jakob Koefoed Tingsgaard, Martin Heyn Sørensen, Annemie Stege Bojer, Robert H. Anderson, David Andrew Broadbent, Sven Plein, Peter Gæde, Per Lav Madsen

    Background: Determination of myocardial blood flow (MBF) with MRI is usually performed with dynamic contrast enhanced imaging (MBFDCE). MBF can also be determined from coronary sinus blood flow (MBFCS), which has the advantage of being a noncontrast technique. However, comparative studies of MBFDCE and MBFCS in large cohorts are lacking.Purpose: To compare MBFCS and MBFDCE in a large cohort.Study Type: Prospective, sequence‐comparison study.Population: 147 patients with type 2 diabetes mellitus (age: 56+/−12 years; 106 male; diabetes duration: 12.9+/−8.1 years), and 25 age‐matched controls.Field Strength/Sequences: 1.5 Tesla scanner. Saturation recovery sequence for MBFDCE vs. phase‐contrast gradient‐echo pulse sequence (free‐breathing) for MBFCS.Assessment: MBFDCE and MBFCS were determined at rest and during coronary dilatation achieved by administration of adenosine at 140 μg/kg/min. Myocardial perfusion reserve (MPR) was calculated as the stress/rest ratio of MBF values. Coronary sinus flow was determined twice in the same imaging session for repeatability assessment.Statistical Tests: Agreement between MBFDCE and MBFCS was assessed with Bland and Altman's technique. Repeatability was determined from single‐rater random intraclass and repeatability coefficients.Results: Rest and stress flows, including both MBFDCE and MBFCS values, ranged from 33 to 146 mL/min/100 g and 92 to 501 mL/min/100 g, respectively. Intraclass and repeatability coefficients for MBFCS were 0.95 (CI 0.90; 0.95) and 5 mL/min/100 g. In Bland–Altman analysis, mean bias at rest was –1.1 mL/min/100 g (CI −3.1; 0.9) with limits of agreement of −27 and 24.8 mL/min/100 g. Mean bias at stress was 6.3 mL/min/100 g (CI −1.1; 14.1) with limits of agreement of −86.9 and 99.9. Mean bias of MPR was 0.11 (CI: −0.02; 0.23) with limits of agreement of −1.43 and 1.64.Conclusion: MBF may be determined from coronary sinus blood flow, with acceptable bias, but relatively large limits of agreement, against the reference of MBFDCE.Level of Evidence: 1Technical Efficacy Stage: 2


  • PO-1731 Evaluation of materials suitable for anthropomorphic multimodality (CT/MRI) phantoms for RT purposes

    by M. Alzahrani, D. Broadbent, I. Teh, B. Al-Qaisieh, A. Walker, R. Lamb, R. Speight

  • Open Access

    176 Myocardial extracellular volume pre and post aortic valve replacement in severe aortic stenosis

    by Noor Sharrack, John D Biglands, Kelvin Chow, David L Buckley, Eylem Levelt, Sven Plein, John P. Greenwood, Peter Kellman, David A Broadbent

    Introduction Histological studies show that myocardial fibrosis accompanies cellular hypertrophy in severe aortic stenosis (AS). Following aortic valve replacement (AVR), left ventricular hypertrophy regresses by 20%-30% by one year (1) and both cellular hypertrophy and fibrosis may regress as early as 6 months post AVR (2, 3). With T1 mapping, CMR can measure diffuse fibrosis by quantifying extracellular volume fraction (ECV) which reflects the fraction of the myocardium occupied by the extracellular matrix and is an independent predictor of mortality and outcome in patients with severe AS (4). Previous methods of measuring T1 and quantifying ECV in patients with severe AS have used Modified Look-Locker Inversion recovery (MOLLI) sequences and have shown a significant reduction in both cell volume and extracellular matrix volume 12 months post AVR(5). We aimed to investigate the changes in ECV seen pre and post AVR, using multiparametric SAturation-recovery single-SHot Acquisition (mSASHA) which has higher accuracy and precision due to its reduced sensitivity to T2 (6). This is particularly important as the T2 of blood changes markedly after contrast administration (7). Methods 16 patients with severe AS referred for AVR were recruited after consent. Mean age was 66 ± 6 years with 56% male. Patients were scanned before (visit 1) and after AVR (visit 2). T1 measurements were made on a 3 T Siemens system using mSASHA before contrast and at 10 minutes post gadobutrol injection (0.15 mmol/kg) as per recommendations by SCMR for calculation of ECV (8) . Derived indexed cell volume and derived indexed matrix volume were calculated from the product of left ventricular mass index ´ [1-ECV] and ECV, respectively as previously described.(5) Results Visit 2 data were acquired 167 ± 44 days post AVR. There was significant reduction in left ventricular hypertrophy, left ventricular end-diastolic volume and left ventricular mass (table 1, figure 1). Post AVR there was a significant reduction in derived indexed cell volume and, while there was a significant increase in ECV, there was no significant change in derived indexed matrix volume (table 2, figure 2). Conclusion For the first time using mSASHA, we have shown that in patients with severe AS, less than 6 months post AVR, there is a significant reduction in cell volume (derived indexed cell volume decreases) with no significant change in matrix volume (derived indexed matrix volume remains stable). Further studies will need to be undertaken to determine if matrix volume decreases at 12 months using mSASHA. Basic CMR parameters pre and post AVR. Results presented as mean ±SD or median (range). P values considered significant at Conflict of Interest No

  • Open Access

    The developmental and professional activities of female international soccer players from five high-performing nations

    by Paul R. Ford, Nicola J. Hodges, David Broadbent, Donna O’cOnnor, Dawn Scott, Naomi Datson, Helena A. Andersson, A. Mark Williams